• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：脂肪酸合酶在人类肝细胞癌中的发病机制、预后及治疗作用

Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.

作者信息

Che Li, Paliogiannis Panagiotis, Cigliano Antonio, Pilo Maria G, Chen Xin, Calvisi Diego F

机构信息

Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, San Francisco, CA, United States.

Department of Medical, Surgical and Experimental Medicine, University of Sassari, Sassari, Italy.

出版信息

Front Oncol. 2022 Apr 12;12:874053. doi: 10.3389/fonc.2022.874053. eCollection 2022.

DOI:10.3389/fonc.2022.874053
PMID:35494002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9040444/
Abstract

[This corrects the article DOI: 10.3389/fonc.2019.01412.].

摘要

[本文更正了文章DOI：10.3389/fonc.2019.01412。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c0/9040444/07c844c22eb0/fonc-12-874053-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c0/9040444/07c844c22eb0/fonc-12-874053-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c0/9040444/07c844c22eb0/fonc-12-874053-g003.jpg

相似文献

1
Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.勘误：脂肪酸合酶在人类肝细胞癌中的发病机制、预后及治疗作用
Front Oncol. 2022 Apr 12;12:874053. doi: 10.3389/fonc.2022.874053. eCollection 2022.
2
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.脂肪酸合酶在人类肝细胞癌中的发病机制、预后及治疗作用
Front Oncol. 2019 Dec 11;9:1412. doi: 10.3389/fonc.2019.01412. eCollection 2019.
3
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.小鼠和人类胆管癌与肝细胞癌中从头脂肪生成的差异需求
Hepatology. 2016 Jun;63(6):1900-13. doi: 10.1002/hep.28508. Epub 2016 Mar 25.
4
Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.乙酰化作用使脂肪酸合酶失稳，从而抑制从头脂肪生成和肿瘤细胞生长。
Cancer Res. 2016 Dec 1;76(23):6924-6936. doi: 10.1158/0008-5472.CAN-16-1597. Epub 2016 Oct 10.
5
Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma.同时靶向从头脂肪生成和胆固醇生物合成是肝细胞癌的一种新型治疗选择。
J Hepatocell Carcinoma. 2021 Jan 28;8:19-21. doi: 10.2147/JHC.S278517. eCollection 2021.
6
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma.脂肪酸合酶在肝细胞癌中对癌基因的依赖性需求
Cell Cycle. 2017 Mar 19;16(6):499-507. doi: 10.1080/15384101.2017.1282586. Epub 2017 Jan 24.
7
Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.脂肪酸合酶在 c-MYC 驱动的肝癌发生中的关键作用。
Int J Mol Sci. 2020 Nov 11;21(22):8467. doi: 10.3390/ijms21228467.
8
Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.勘误：与原发性胆汁酸生物合成及肝细胞癌肿瘤微环境相关的线粒体相关预后生物标志物的鉴定。
Front Oncol. 2022 Jan 17;11:843623. doi: 10.3389/fonc.2021.843623. eCollection 2021.
9
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.胆固醇生物合成支持脂肪酸合酶缺失的肝癌病变在小鼠和人类中的生长。
Gut. 2020 Jan;69(1):177-186. doi: 10.1136/gutjnl-2018-317581. Epub 2019 Apr 6.
10
Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.勘误：单细胞转录组分析揭示恶性肝细胞亚群的代谢变化及预后价值并预测肝细胞癌的新治疗药物。
Front Oncol. 2023 Mar 8;13:1162375. doi: 10.3389/fonc.2023.1162375. eCollection 2023.

引用本文的文献

1
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications.生长抑素受体2在肝细胞癌中的过表达：对癌症生物学及治疗应用的影响
Curr Oncol. 2025 Sep 13;32(9):512. doi: 10.3390/curroncol32090512.